$2.44T
Total marketcap
$73.38B
Total volume
BTC 50.86%     ETH 14.97%
Dominance

Cybin CYBN Stock

0.35 USD {{ price }} 1.000004% {{change_pct}}%
Market Cap
288.57M USD
LOW - HIGH [24H]
0.36 - 0.39 USD
VOLUME [24H]
7.44M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.22 USD

Cybin Price Chart

Cybin CYBN Financial and Trading Overview

Cybin stock price 0.35 USD
Previous Close 0.25 USD
Open 0.25 USD
Bid 0.25 USD x 800
Ask 0.25 USD x 1400
Day's Range 0.25 - 0.28 USD
52 Week Range 0.21 - 1.14 USD
Volume 2.78M USD
Avg. Volume 1.3M USD
Market Cap 52.73M USD
Beta (5Y Monthly) 1.88952
PE Ratio (TTM) N/A
EPS (TTM) -0.22 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 4.38 USD

CYBN Valuation Measures

Enterprise Value 26.4M USD
Trailing P/E N/A
Forward P/E -1.375
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.9322035
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.489

Trading Information

Cybin Stock Price History

Beta (5Y Monthly) 1.88952
52-Week Change -51.83%
S&P500 52-Week Change 20.43%
52 Week High 1.14 USD
52 Week Low 0.21 USD
50-Day Moving Average 0.31 USD
200-Day Moving Average 0.44 USD

CYBN Share Statistics

Avg. Volume (3 month) 1.3M USD
Avg. Daily Volume (10-Days) 2.32M USD
Shares Outstanding 191.76M
Float 156.66M
Short Ratio 2.43
% Held by Insiders 22.28%
% Held by Institutions 7.86%
Shares Short 2.92M
Short % of Float N/A
Short % of Shares Outstanding 1.52%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 149:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End March 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -43.43%
Return on Equity (ttm) -71.33%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -53938000 USD
Net Income Avi to Common (ttm) -51867000 USD
Diluted EPS (ttm) -0.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 22.64M USD
Total Cash Per Share (mrq) 0.12 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 6.891
Book Value Per Share (mrq) 0.295

Cash Flow Statement

Operating Cash Flow (ttm) -46314000 USD
Levered Free Cash Flow (ttm) -32884624 USD

Profile of Cybin

Country United States
State ON
City Toronto
Address 100 King Street West
ZIP M5X 1C9
Phone N/A
Website https://www.cybin.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 50

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Q&A For Cybin Stock

What is a current CYBN stock price?

Cybin CYBN stock price today per share is 0.35 USD.

How to purchase Cybin stock?

You can buy CYBN shares on the NYSE American exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cybin?

The stock symbol or ticker of Cybin is CYBN.

Which industry does the Cybin company belong to?

The Cybin industry is Biotechnology.

How many shares does Cybin have in circulation?

The max supply of Cybin shares is 816.32M.

What is Cybin Price to Earnings Ratio (PE Ratio)?

Cybin PE Ratio is now.

What was Cybin earnings per share over the trailing 12 months (TTM)?

Cybin EPS is -0.22 USD over the trailing 12 months.

Which sector does the Cybin company belong to?

The Cybin sector is Healthcare.